Raymond James & Associates Aurora Cannabis Inc Transaction History

Raymond James & Associates

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$0.42 - $0.57 $1,033 - $1,402	-2,461 Reduced 13.98%	15,143 $7,000
Q3 2023 Oct 24, 2023	SELL	$0.44 - $0.98 $380 - $846	-864 Reduced 4.68%	17,604 $10,000
Q2 2023 Jul 25, 2023	SELL	$0.5 - $0.67 $94 - $126	-189 Reduced 1.01%	18,468 $9,000
Q1 2023 Apr 14, 2023	SELL	$0.66 - $1.13 $1,089 - $1,864	-1,650 Reduced 8.13%	18,657 $13,000
Q4 2022 Feb 08, 2023	SELL	$0.85 - $1.54 $349 - $632	-411 Reduced 1.98%	20,307 $18,000
Q3 2022 Oct 25, 2022	SELL	$1.16 - $1.89 $1,251 - $2,039	-1,079 Reduced 4.95%	20,718 $25,000
Q2 2022 Aug 12, 2022	SELL	$1.23 - $4.14 $13,111 - $44,132	-10,660 Reduced 32.84%	21,797 $29,000
Q1 2022 May 11, 2022	BUY	$2.93 - $5.89 $45,962 - $92,396	15,687 Added 93.54%	32,457 $130,000
Q4 2021 Feb 08, 2022	BUY	$5.41 - $8.5 $25,794 - $40,528	4,768 Added 39.73%	16,770 $91,000
Q3 2021 Nov 02, 2021	SELL	$5.95 - $8.88 $24,698 - $36,860	-4,151 Reduced 25.7%	12,002 $83,000
Q2 2021 Aug 11, 2021	BUY	$6.86 - $10.23 $29,991 - $44,725	4,372 Added 37.11%	16,153 $146,000
Q1 2021 May 14, 2021	BUY	$8.96 - $18.92 $105,557 - $222,896	11,781 New	11,781 $110,000
Q3 2020 Nov 04, 2020	SELL	$4.65 - $12.87 $132,771 - $367,477	-28,553 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$5.8 - $17.4 $165,607 - $496,822	28,553 New	28,553 $353,000

9.14M

Ticker ACB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 300,436,992
Market Cap $1.34B
Description
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried ...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.